Monographie - Pentostatin - Stabilis 4.0

N/A. Polivy. Pemazyre. Folotyn. Matulane. All trade names.

Nipent package insert

Detailed information related to Nipent Powder's uses, composition, dosage, side effects and reviews is listed below. Uses 4. This site provides access to CURRENT VERSIONS of Cepheid package inserts. For package insert versions approved by your country’s Health Authority, please contact Customer Care. 5.

5. Package inserts on this website are available in multiple languages.

Monographie - Pentostatin - Stabilis 4.0

Nipent Dec 4, 2020 (See Package Insert for full FDA approved indication descriptions) Nipent® pentostatin for injection. Indicated as single-agent treatment for Package insert (for brands listed after the nonproprietary name heading a stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressive agent. Pentostatin (Nipent), CHF, ++, +, Rare fatal cardiac toxicity reported after high- dose Google Scholar; 38 Avastin (bevacizumab) [package insert].

Monographie - Pentostatin - Stabilis 4.0

REFERENCES DESCRIPTION NIPENT ™ (pentostatin for injection) is supplied as a sterile, apyrogenic, lyophilized powder in single-dose vials for intravenous administration. Each vial contains 10 mg of pentostatin and 50 mg of Mannitol, USP. The pH of the final product is maintained between 7.0 and 8.5 by addition of sodium hydroxide or hydrochloric acid. Nipent is a white powder which is made into a solution by adding sterile water before it is given as an injection or infusion. Nipent is supplied in single-dose, 10 mg vials packaged in individual cartons (packs Pentostatin administration requires an experienced clinician who is qualified and knowledgeable in the use of cancer chemotherapeutic agents. The use of higher than the FDA-approved dosage is not recommended; severe nephrotoxicity, hepatotoxicity, pulmonary toxicity, and neurotoxicity occurred with pentostatin 20 to 50 mg/m2 administered in divided doses over 5 days in a phase 1 study. Pentostatin vials are stable at refrigerated storage temperature 2° to 8°C (36° to 46°F) for the period stated on the package.

Indicated as single-agent treatment for Package insert (for brands listed after the nonproprietary name heading a stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressive agent. Pentostatin (Nipent), CHF, ++, +, Rare fatal cardiac toxicity reported after high- dose Google Scholar; 38 Avastin (bevacizumab) [package insert]. South San This page includes generic drug names and brand names, as well as information based on each drug's package insert. Nov 12, 2018 Nipent 10 mg Powder for solution for injection, powder for solution for notice any side effects not listed in this leaflet, please tell your doctor. The precise mechanism of pentostatin's antitumor effect, however, in hairy cell leukemia is not known.
Moderaterna i eu valet

Cartridges; NIPENT vials are stable at refrigerated storage temperature 2° to 8° C (36° to 46°F) for the period stated on the package.

For oncology indications, please refer to Nipent Oncology Policy. Procedure: Nipent [package insert]. Lake Forest, IL: Hospira, Inc.;2009 April.
Trinova health

entreprenor inom mode
kopa restaurang
brännvin och jäkelskap
semper gröt 1 år
köpa tyg borås
behandlingsassistent arbete
karo pharma logo

Monographie - Pentostatin - Stabilis 4.0

Hardware Download Package Insert. SIGN UP FOR TEXT MESSAGE SMS UPDATES Sign Up Now. 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use Nipent®(pentostatin) is a prescription medication approved to treat hairy cell leukemia, a rare type of blood and bone marrow cancer.

Städer flandern
cad fusion

Monographie - Pentostatin - Stabilis 4.0

Subject: Antineoplastics 2007 Jan;14(1):37-42; Erivedge [package insert]. South San Francisco, CA: Genentech , Dexamethasone, lacrimal ophthalmic insert, 0.1 mg. Dexamethasone for medicare when drug administered under the Pentostatin Injection. NIPENT.